Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OTRK
3426
DELISTED
Ontrak
OTRK
| $922K | ﹤0.01% |
315
-49
| -13% | -$142K |
|
3427
Flywire
FLYW
$2.22B
| $919K | ﹤0.01% |
+25,000
| New | +$838K |
|
3428
CuriosityStream
CURI
$237M
| $916K | ﹤0.01% |
+67,131
| New | +$867K |
|
|
BVH
3429
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $911K | ﹤0.01% |
50,585
+7,474
| +17% | +$147K |
|
3430
GT Biopharma
GTBP
$10.7M
| $910K | ﹤0.01% |
+1,957
| New | +$813K |
|
|
GPX
3431
DELISTED
GP Strategies Corp.
GPX
| $909K | ﹤0.01% |
57,851
-1,519
| -3% | -$24.6K |
|
|
WBII
3432
DELISTED
WBI BullBear Global Income ETF
WBII
| $899K | ﹤0.01% |
36,127
+672
| +2% | +$16.6K |
|
|
CSLT
3433
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $898K | ﹤0.01% |
341,710
+297,154
| +667% | +$554K |
|
3434
ROBO Global Robotics & Automation Index ETF
ROBO
$2.13B
| $896K | ﹤0.01% |
13,731
+1
| +0% | +$64 |
|
3435
XBiotech
XBIT
$75M
| $896K | ﹤0.01% |
54,119
-7,286
| -12% | -$124K |
|
3436
Adicet Bio
ACET
$77.3M
| $895K | ﹤0.01% |
5,437
+2,762
| +103% | +$563K |
|
3437
Apyx Medical
APYX
$126M
| $891K | ﹤0.01% |
86,370
-22,347
| -21% | -$221K |
|
3438
Oscar Health
OSCR
$9.5B
| $891K | ﹤0.01% |
+41,451
| New | +$992K |
|
3439
Teekay Tankers
TNK
$2.81B
| $885K | ﹤0.01% |
+61,378
| New | +$879K |
|
|
GBL
3440
DELISTED
GAMCO Investors, Inc.
GBL
| $885K | ﹤0.01% |
35,256
+254
| +0.7% | +$5.78K |
|
|
BFIN
3441
DELISTED
BankFinancial
BFIN
| $883K | ﹤0.01% |
77,125
-63,612
| -45% | -$681K |
|
3442
PIMCO Dynamic Income Fund
PDI
$7.33B
| $883K | ﹤0.01% |
30,643
-1,765
| -5% | -$51K |
|
|
SQZ
3443
DELISTED
SQZ Biotechnologies Company
SQZ
| $881K | ﹤0.01% |
61,013
+47,792
| +361% | +$624K |
|
3444
Cedar Fair
FUN
$1.68B
| $877K | ﹤0.01% |
19,571
| – | – |
|
3445
inTEST
INTT
$179M
| $874K | ﹤0.01% |
52,117
+29,233
| +128% | +$395K |
|
|
DZSI
3446
DELISTED
DZS Inc. Common Stock
DZSI
| $874K | ﹤0.01% |
42,115
+5,767
| +16% | +$100K |
|
3447
DarioHealth
DRIO
$72.9M
| $870K | ﹤0.01% |
+2,037
| New | +$776K |
|
|
PRTK
3448
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $869K | ﹤0.01% |
127,447
-2,836
| -2% | -$22.9K |
|
|
AGS
3449
DELISTED
PlayAGS
AGS
| $867K | ﹤0.01% |
87,638
-13,030
| -13% | -$120K |
|
3450
Prelude Therapeutics
PRLD
$428M
| $866K | ﹤0.01% |
30,254
-782
| -3% | -$27.8K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.